EBR Systems, Inc. reported the first quarter ended March 31, 2026 results: revenue US$2.25M to US$2.36M.
“in 41 commercial patients during the quarter, bringing total implants across the pilot phase and Limited Market Release to 71 · EBR expects to report revenue in the range of US$2.25M to US$2.36M for Q1 2026, based on preliminary unaudited quarter-end results and subject to quarter-end closing adjustments · The Limited Market Release continued to advance in”
Governance Changes
EBR Systems, Inc.: Certificate of Amendment filed to effect a 1-for-10 reverse stock split of common stock, effective April 1, 2026 (effective 2026-04-01).
“On March 26, 2026, EBR Systems, Inc. (the “Company”) filed a Certificate of Amendment to its Amended and Restated Certificate of Incorporation (the “Charter Amendment”) with the Secretary of State of the State of Delaware to effect a one-for-ten (1:10) reverse stock split (the “Reverse Stock Split”) of the Company's common stock, par value $0.0001 per share (the “Common Stock”), with an effective date and time for the Reverse Stock Split of April 1, 2026 at 4:00 a.m., Eastern Time (the “Effective Time”).”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.